Skip to main content
. 2020 Jul 28;35(30):e280. doi: 10.3346/jkms.2020.35.e280

Table 1. Baseline demographic and clinical characteristics.

Characteristics Overall cohort (n = 3,060) Disease severity on admissiona P value
1–2 (n = 2,585) 3–4 (n = 141) 5–8 (n = 55)
Age, yrb 43 (26–57) 40 (25–54) 63 (55–76) 70 (61–79) < 0.001
< 5 15/3,058 (0.5) 13/2,583 (0.5) 1/141 (0.7) 0/55 (0.0) < 0.001d
5–14 49/3,058 (1.6) 46/2,583 (1.8) 0/141 (0.0) 0/55 (0.0)
15–44 1,515/3,058 (49.5) 1,392/2,583 (53.9) 10/141 (0.4) 1/55 (1.8)
45–64 1,081/3,058 (35.4) 885/2,583 (34.3) 66/141 (46.8) 16/55 (29.1)
≥ 65 398/3,058 (13.0) 247/2,583 (9.6) 64/141 (45.4) 38/55 (69.1)
Male 1,334/3,059 (43.6) 1,122/2,584 (43.4) 82/141 (58.2) 30/55 (54.6) 0.001
Time from illness onset to hospital admission, daysc n = 2,710 n = 2,280 n = 130 n = 45 0.546
5 (2–9) 4 (2–9) 4 (1–9) 7 (3–10)
Vital signs on admission
Respiratory rate, ≥ 22 per min 194/2,895 (6.5) 121/2,525 (4.8) 18/139 (13.0) 36/53 (67.9) < 0.001
Pulse, ≥ 120 beats per min 77/3,009 (2.6) 61/2,546 (2.4) 3/140 (2.1) 6/55 (10.9) < 0.001d
Systolic blood pressure, ≤ 100 mmHg 121/2,992 (4.0) 89/2,529 (3.5) 5/140 (3.6) 7/55 (12.7) 0.002d
Symptoms on admission
Altered mental status 7/2,944 (0.2) 1/2,515 (0.0) 2/132 (2.3) 2/34 (5.9) < 0.001d
History of fever 851/2,954 (28.8) 652/2,516 (25.9) 88/131 (67.2) 30/42 (70.4) < 0.001
Cough 1,204/2,949 (40.8) 999/2,518 (39.7) 70/131 (53.4) 20/35 (57.1) 0.001
Sputum 761/2,943 (25.9) 636/2,515 (25.3) 55/130 (42.3) 15/34 (44.1) < 0.001
Rhinorrhea 357/2,933 (12.2) 322/2,513 (12.8) 8/127 (6.3) 3/31 (9.7) 0.085d
Sore throat 592/2,923 (20.3) 515/2,504 (20.6) 22/125 (17.6) 7/33 (21.2) 0.720
Dyspnea 217/2,939 (7.4) 121/2,508 (4.8) 46/130 (35.4) 26/37 (70.3) < 0.001
Myalgia 570/2,929 (19.5) 467/2,510 (18.6) 39/126 (31.0) 13/32 (40.6) < 0.001
Diarrhea 209/2,927 (7.1) 173/2,506 (6.9) 16/128 (12.5) 3/34 (8.8) 0.054
Nausea or vomiting 80/2,926 (2.7) 61/2,505 (2.4) 7/128 (5.5) 2/32 (6.3) 0.049d
Comorbidity
Diabetes 253/3,015 (8.4) 161/2,551 (6.3) 35/140 (25.0) 20/55 (36.4) < 0.001
Hypertension 477/3,014 (15.8) 331/2,551 (13.0) 61/139 (46.0) 27/55 (49.1) < 0.001
Chronic heart disease 68/2,898 (2.3) 52/2,506 (2.1) 6/138 (4.4) 5/54 (9.3) 0.004d
Asthma 56/2,958 (1.9) 45/2,550 (1.8) 5/140 (3.6) 3/55 (5.5) 0.048d
Chronic kidney disease 28/3,013 (0.9) 10/2,549 (0.4) 12/140 (8.6) 2/55 (3.6) < 0.001d
Malignancy 47/3,012 (1.6) 30/2,549 (1.2) 8/140 (5.7) 6/55 (10.9) < 0.001d
Dementia 65/2,621 (2.5) 31/2,187 (1.4) 20/127 (15.8) 7/55 (12.7) < 0.001d
Obesity (BMI, ≥ 30 kg/m2) 152/2,976 (5.1) 133/2,519 (5.3) 6/138 (4.4) 755 (12.7) 0.084
Underweight (BMI, < 18.5 kg/m2) 336/2,976 (11.3) 288/2,519 (11.4) 18/138 (13.0) 9/55 (16.4)
Current smoker 195/2,769 (7.0) 184/2,359 (7.8) 6/112 (5.4) 2/43 (4.7) 0.483
Infiltration in chest X-ray on admission < 0.001
None 1,749/2,557 (68.4) 1,541/2,131 (72.3) 22/119 (18.5) 2/52 (3.9)
Unilateral 356/2,557 (13.9) 293/2,131 (13.8) 36/119 (30.3) 1/52 (1.9)
Bilateral 452/2,557 (17.7) 297/2,131 (13.9) 61/119 (51.3) 49/52 (94.2)

Data are presented as median (interquartile range) or number (%), unless otherwise indicated.

BMI = body mass index, ECMO = extracorporeal membrane oxygenation.

a1, no limitation of daily activities; 2, limitation of daily activities but no need for supplemental oxygen therapy; 3, need for supplemental oxygen therapy via nasal cannula; 4, need for supplemental oxygen therapy via facial mask; 5, need for high-flow supplemental oxygen therapy or non-invasive mechanical ventilation; 6, need for invasive mechanical ventilation; 7, multi-organ failure or need for ECMO therapy; 8, death. Patients with no disease severity score on admission day (279, 9.1%) were excluded from this analysis; bData regarding age were missing for 2 patients (0.1%); cData regarding illness onset were missing for 350 patients (11.4%); dFisher's exact test.